Clinical Trial Update: Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating azathioprine to prevent postoperative recurrence of ileal Crohn's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Azathioprine (azathioprine)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Crohn Disease, Recurrence | Phase 2 | Status: TERMINATED